Atria Investments’s Checkpoint Therapeutics CKPT Stock Holding History

Atria Investments’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,920	Closed	-$141K	–	2000
2025 Q1	$141K	Sell	34,920 -2,375	-6%	-$7.92K	﹤0.01%	1853
2024 Q4	$119K	Sell	37,295 -10,636	-22%	-$36.1K	﹤0.01%	1824
2024 Q3	$107K	Sell	47,931 -12	-0%	-$28	﹤0.01%	1871
2024 Q2	$103K	Buy	+47,943	New	+$85.4K	﹤0.01%	1864

Atria Investments's CKPT Position: Q2 2025 in Review

Atria Investments sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 34,920 shares — an estimated $141K sold.

Atria Investments first reported a position in CKPT in Q2 2024 and held it in 4 quarters. The position peaked at $141K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Atria Investments reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Atria Investments sold 34,920 Checkpoint Therapeutics shares in Q2 2025, an estimated $141K.
Atria Investments first reported a position in Checkpoint Therapeutics in Q2 2024 and held it in 4 quarters.
Atria Investments's Checkpoint Therapeutics position peaked at $141K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.